The results are a pivotal achievement for psychedelic medicines. More than 100m people worldwide struggle with depression that does not respond to conventional treatments, and psychedelics have long ...

Psychedelic therapy often promises transcendent mystical experiences. But research suggests context and expectation may ...

In his new book A World Appears, the journalist explores the mysteries of the human brain — and whether computers could ever ...

Psychedelic drug development can still benefit from the FDA Commissioner’s National Priority Review Voucher Pilot Program, though the CNPV designation was not given to Compass Pathways’ synthetic ...

Cybin D/B/A Helus Pharma (NASDAQ:HELP) is among the 7 Most Promising Psychedelic Stocks According to Hedge Funds. The seventh stock on our list of most promising stocks is Cybin D/B/A Helus Pharma ...

Dimethyltryptamine’s short duration of psychedelic effects makes it a potentially practical alternative to other longer-acting psychedelic therapies such as psilocybin.

Discover three groundbreaking research developments: chick sound-shape connections, data storage in glass, and promising psychedelic depression treatment.

Nearly one in four Americans now believe that the use of psilocybin or “magic” mushrooms should be legal as 10 million report ...

Oregon took a leap into the psychedelic unknown when voters approved regulated psilocybin services nearly six years ago to treat addiction, depression and other illnesses. Since then, thousands of ...

Michael Pollan’s lucid and lively writing on the science of everyday life—plant biology, nutrition, cooking—has made him one of the most popular nonfiction writers around. I ...